Reduces appetite and increases feelings of fullness (satiety), leading to reduced caloric intake
The side effect profile of Wegovy is well known
Tracking data from clinical participants showed those consistently hitting 70+ ounces of water daily experienced zero serious complications
Instead, it creates conditions for fat loss by reducing appetite and caloric intake through GIP and GLP-1 receptor activation, which leads to an energy deficit that promotes fat mobilization and oxidation
For those exploring GLP-1 therapy, TrimRX offers personalized programs, including tailored consultations, prescriptions, and ongoing support to help ensure safe and effective results
Retatrutide subcutaneous injections involve less depth, smaller volumes per injection, and no immune-triggering adjuvants